The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Characterization of $ET_B$ Receptor-mediated Relaxation in Precontracted Mesenteric Artery from Streptozotocin-induced Diabetic Rats

  • Eom, Yang-Ki (Department of Pharmacology, College of Medicine, Pusan National University) ;
  • Kim, Koan-Hoi (Department of Pharmacology, College of Medicine, Pusan National University) ;
  • Rhim, Byung-Yong (Department of Pharmacology, College of Medicine, Pusan National University)
  • Published : 2005.10.21
Download PDF
⟨ Previous Next ⟩

Abstract

Diabetes mellitus is associated with vascular complications, including an impairment of vascular function and alterations in the reactivity of blood vessels to vasoactive substances in various vasculature. In the present study, the authors have observed endothelin-B ($ET_B$) receptor agonist-induced relaxation in precontracted mesenteric arterial segments from streptozotocin (STZ)-induced diabetic rats, which was not shown from control rats or in other arterial segments from diabetic rats. Accordingly, the goal of this study was to investigate in what way STZ-induced diabetes altered reactivity of the mesenteric arterial bed and to examine the causal relaxation, if any, between this $ET_B$ receptor-mediated relaxation and endothelial paracrine function, especially nitric oxide (NO) production. The relaxation induced by $ET_B$ agonists was not observed in mesenteric arteries without endothelium. The relaxation to $ET_B$ agonists was completely abolished by pretreatment with BQ788, but not by BQ610. $N_{\omega}-nitro-L-arginine$ methyl ester and soluble guanylate cyclase inhibitors, methylene blue or LY83583 significantly attenuated the relaxant responses to $ET_B$ agonists, respectively. When the expression of eNOS and iNOS was evaluated on agarose gel stained with ethidium bromide, the expression of eNOS mRNA in diabetic rats was significantly decreased, but the expression of iNOS was increased compared with control rats. Furthermore, the iNOS-like immunostaining was densely detected in the endothelium and slightly in the arterial smooth muscle of diabetic rats, but not in control rats. These observations suggest that $ET_B$ receptor may not play a role in maintaining mesenteric vascular tone in normal situation. However, the alterations in $ET_B$ receptor sensitivity were found in diabetic rats and lead to the $ET_B$ agonist-induced vasorelaxation, which is closely related to NO production. In the state of increased vascular resistance of diabetic mesenteric vascular bed, enhanced NO production by activation of iNOS could lead to compensatory vasorelaxation to modulate adequate perfusion pressure to splanchnic area.

Keywords

References

  1. Aboot RD, Donahue RP, Macmahon SW, Reed DM, Yano K. Diabetes and the risk of stroke. J Am Med Assoc 257: 949-952, 1987 https://doi.org/10.1001/jama.257.7.949
  2. Allcock GH, Battistini B, Fournier A, Warner TD, Vane JR. Characterization of endothelin receptors mediating mechanical responses to the endothelins in the isolated stomach strip of the rat. J Pharmacol Exp Ther 275: 120-126, 1995
  3. Beech DJ, Bolton TB. Properties of the cromakalim-induced potassium conductance in smooth muscle cells isolated from the rabbit portal vein. Br J Pharmacol 98: 851-864, 1989 https://doi.org/10.1111/j.1476-5381.1989.tb14614.x
  4. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976 https://doi.org/10.1016/0003-2697(76)90527-3
  5. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin- requiring enzyme. Proc Natl Acad Sci USA 87: 682-685, 1990 https://doi.org/10.1073/pnas.87.2.682
  6. Brothers TE, Grubbs AL, Zhang Y, Ergul A. Selective downregulation of endothelin-B receptors in diabetic African-American patients. Ethn Dis 12(S1): 46-50, 2002
  7. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 26: 87-90, 1990 https://doi.org/10.1016/0014-5793(72)80548-9
  8. Cardell LO, Uddman R, Edvinsson L. Evidence for multiple endothelin receptors in the guinea-pig pulmonary artery and trachea. Br J Pharmacol 105: 376-380, 1992 https://doi.org/10.1111/j.1476-5381.1992.tb14261.x
  9. Chou YC, Perng JC, Juan CC, Jang SY, Kwok CF, Chen WL, Fong JC, Ho LT. Endothelin-1 inhibits insulin-stimulated glucose uptake in isolated rat adipocytes. Biochem Biophys Res Commun 202: 688-693, 1994 https://doi.org/10.1006/bbrc.1994.1985
  10. Cohen RA, Sheppherd JT, Vanhoutte PM. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science 221: 273-274, 1983 https://doi.org/10.1126/science.6574604
  11. Colwell JA, Halushka PV, Sargi KE, Lopesvirella MF, Sagel J. Vascular disease in diabetes. Pathophysiological mechanisms and therapy. Arch Intern Med 139: 225-230, 1979 https://doi.org/10.1001/archinte.139.2.225
  12. De Juan JA, Moya FJ, Ripodas A, Bernal R, Fernandez-Cruz A, Fernandez-Durango R. Changes in the density and localization of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment. Diabetologia 43: 773-785, 2000 https://doi.org/10.1007/s001250051375
  13. Deng D, Evans T, Mukherjee K, Downey D, Chakrabarti S. Diabetes- induced vascular dysfunction in the retina: role of endothelins. Diabetologia 42: 1228-1234, 1999 https://doi.org/10.1007/s001250051296
  14. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85: 9797－9800, 1988 https://doi.org/10.1073/pnas.85.24.9797
  15. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-974, 2000 https://doi.org/10.1038/sj.bjp.0703393
  16. Eglezos A, Cucchi P, Patacchini R, Quartara L, Maggi CA, Mizrahi J. Differential effects of BQ-123 against endothelin-1 and endothelin- 3 on the rat vas deferens: evidence for an atypical endothelin receptor. Br J Pharmacol 109: 736-738, 1993 https://doi.org/10.1111/j.1476-5381.1993.tb13635.x
  17. Evans T, Xi Deng D, Mukherjee K, Downey D, Chakrabarti S. Endothelins, their receptors, and retinal vascular dysfunction in galactose-fed rats. Diabetes Res Clin Pract 48: 75-85, 2000 https://doi.org/10.1016/S0168-8227(99)00143-6
  18. Feletou M, Vanhoutte PM. The alternative: EDHF. J Mo Cell Cardiol 31: 15-22, 1999 https://doi.org/10.1006/jmcc.1998.0840
  19. Forstermann U, Schmidt HH, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42: 1849-1857, 1991 https://doi.org/10.1016/0006-2952(91)90581-O
  20. Fulton DJ, Hodgson WC, Sikorski BW, King RG. Attenuated responses to endothelin-1, KCl and $CaCl_{2}$, but not noradrenaline, of aortae from rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 104: 928-932, 1991 https://doi.org/10.1111/j.1476-5381.1991.tb12528.x
  21. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018, 1989
  22. Gellai M, Fletcher T, Pullen M, Nambi P. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol 271: R254-R261, 1996
  23. Griffith TM, Edwards DH, Lewis MJ, Henderson AH. Evidence that cyclic guanosine monophosphate (cGMP) mediates endotheliumdependent relaxation. Eur J Pharmacol 112: 195-202, 1985 https://doi.org/10.1016/0014-2999(85)90496-0
  24. Gruetter CA, Kadowitz PJ, Ignarro LJ. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can J Physiol Pharmacol 59: 150-156, 1981 https://doi.org/10.1139/y81-025
  25. Hattori Y, Kasai K, Nakamura T, Emoto T, Shimoda SI. Effect of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Metabolism 40: 165-169, 1991 https://doi.org/10.1016/0026-0495(91)90168-V
  26. Heath H, Brigden WD, Canever JV. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 7: 308-315, 1971 https://doi.org/10.1007/BF01219463
  27. Hocher B, Schwarz A, Reinbacher D, Jacobi J, Lun A, Priem F, Bauer C, Neumayer HH, Raschack M. Effects of endothelin receptor antagonists on the progression of diabetic nephropathy. Nephron 87: 161-169, 2001 https://doi.org/10.1159/000045906
  28. Hodgson WC, King RG. Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin-1 of aortic rings from streptozptocin-induced diabetic rats. Br J Pharmacol 106: 644-649, 1992 https://doi.org/10.1111/j.1476-5381.1992.tb14389.x
  29. Huggins JP, Pelton JT, Miller RC. The structure and specificity of endothelin receptors: their importance in physiology and medicine. Pharmacol Ther 59: 55-123, 1993 https://doi.org/10.1016/0163-7258(93)90041-B
  30. Ignarro LJ, Kadowitz PJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 25: 171-191, 1985 https://doi.org/10.1146/annurev.pa.25.040185.001131
  31. Ikeda K, Wada Y, Sanematsu H, Foster HE Jr, Shin D, Weiss RM, Latifpour J. Regulatory effect of experimental diabetes on the expression of endothelin receptor subtypes and their gene transcripts in the rat adrenal gland. J Endocrinol 168: 163-175, 2001 https://doi.org/10.1677/joe.0.1680163
  32. Inoue A, Yanagisawa M, Kimura S, Yoshitoshi K, Miyauchi T, Goto K, Masaki T. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863-2867, 1989 https://doi.org/10.1073/pnas.86.8.2863
  33. Itoh Y, Yanagisawa M, Ohkubo S, Kimura C, Kosaka T, Inoue A, Ishida N, Mitsui Y, Onda H, Fujino M, Masaki T. Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin. FEBS Lett 231: 440-444, 1988 https://doi.org/10.1016/0014-5793(88)80867-6
  34. Jang JK, Kang YJ, Seo HG, Seo SJ, Chang KC. Enhanced expression of inducible nitric oxide synthase may be responsible for altered vascular reactivity in streptozotocin-induced diabetic rats. Korean J Physiol Pharmacol 3: 375-382, 1999
  35. Juan CC, Fang VS, Huang YJ, Kwok CF, Hsu YP, Ho LT. Endothelin- 1 induces insulin resistance in conscious rats. Biochem Biophys Res Commun 227: 694-699, 1996 https://doi.org/10.1006/bbrc.1996.1571
  36. Karaki H, Sudjarwo SA, Hori M, Takai M, Urade Y, Okada T. Induction of endothelium-dependent relaxation in the rat aorta by IRL 1620, a novel and selective agonist at endothelin $ET_{B}$ receptor. Br J Pharmacol 109: 486-490, 1993 https://doi.org/10.1111/j.1476-5381.1993.tb13595.x
  37. Kawai Y, Ohhashi T. Prostaglandin $F2\alpha$-induced endotheliumdependent relaxation in isolated monkey cerebral arteries. Am J Physiol 260: H1538-H1543, 1991
  38. Lavy S, Melamed E, Cahane E, Carmon A. Hypertension and diabetes as risk factors in stroke patients. Stroke 4: 751-759, 1973 https://doi.org/10.1161/01.STR.4.5.751
  39. Levin ER. Endothelins. N Engl J Med 333: 356-363, 1995 https://doi.org/10.1056/NEJM199508103330607
  40. Lorenzi M. Glucose toxicity in the vascular complications of diabetes: the cellular perspective. Diabetes Metab Rev 8: 85-103, 1992 https://doi.org/10.1002/dmr.5610080202
  41. Makita Z, Yanagisawa K, Kuwalima S, Bucala R, Vlassara H, Koike T. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis. Nephrol Dial Transplant 5(Suppl 11): 31-33, 1996
  42. Malta E, Macdonald PS, Dusting GJ. Inhibition of vascular smooth muscle relaxation by LY83583. Naunyn-Schmiedeberg's Arch Pharmacol 337: 459-464, 1988
  43. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 232: 708-716, 1985
  44. Martine C, Gillian AG, Volker B, Bernd Michael L, Rolf O. The endothelin $ET_{B}$ receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 186: 867- 873, 1992. https://doi.org/10.1016/0006-291X(92)90826-7
  45. Mayne EE, Bridges JM, Weaver JA. Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus. Diabetologia 6: 436-440, 1970 https://doi.org/10.1007/BF01212078
  46. McCall TB, Boughton-Smith NK, Palmer RM, Whittle BJ, Moncada S. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J 261: 293-296, 1989
  47. Meraji S, Joyakody L, Senaratine MPJ, Thomson ABR, Kappagoda T. Endothelium-dependent relaxation in aorta of BB rat. Diabetes 36: 978-981, 1987 https://doi.org/10.2337/diabetes.36.8.978
  48. Moncada S, Palmer RM. Biosynthesis and actions of nitric oxide. Semin Perinatol 15: 16-19, 1991
  49. Moore PK, al-Swayeh OA, Chong NW, Evans RA, Gibson A. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. Br J Pharmacol 99: 408-412, 1990 https://doi.org/10.1111/j.1476-5381.1990.tb14717.x
  50. Moore SA, Bohlen HG, Miller BG, Evans AP. Cellular and vessel wall morphology of cerebral cortical arterioles after short-term diabetes in adult rats. Blood Vessels 22: 265-277, 1985
  51. Ottosson-Seeberger A, Lundberg JM, Alvestrand A, Ahlborg G. Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol Scand 161: 211-220, 1997 https://doi.org/10.1046/j.1365-201X.1997.00212.x
  52. Oyama Y, Kawasaki H, Hattori Y, Kanno M. Attenuation of endothelium- dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 131: 75-78, 1986 https://doi.org/10.1016/0014-2999(86)90517-0
  53. Quandt FN. Three kinetically distinct potassium channels in mouse neuroblastoma cells. J Physiol 395: 401-418, 1988
  54. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 87: 10043-10047, 1990 https://doi.org/10.1073/pnas.87.24.10043
  55. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res 52: 352-357, 1983 https://doi.org/10.1161/01.RES.52.3.352
  56. Ruderman NB, Williamson JR, Brownee M. Glucose and diabetic vascular disease. FASEB J 6: 2905-2914, 1992
  57. Rudy B. Diversity and ubiquity of K channels. Neuroscience 25: 729-749, 1988 https://doi.org/10.1016/0306-4522(88)90033-4
  58. Sagel J, Colwell JA, Crook L, Laimins M. Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 82: 733- 738, 1975 https://doi.org/10.7326/0003-4819-82-6-733
  59. Saito M, Wada Y, Ikeda K, Wang Z, Foster HE Jr, Smith SD, Weiss RM. Expression of endothelin receptor subtypes and their messenger RNAs in diabetic rat prostate: effect of insulin treatment. Mol Cell Biochem 210: 1-12, 2000 https://doi.org/10.1023/A:1007041909477
  60. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T. Clonong of a cDNA encoding a non- isopeptideselective subtype of the endothelin receptor. Nature 348: 732-735, 1990 https://doi.org/10.1038/348732a0
  61. Schilling L, Feger GI, Ehrenreich H, Wahl M. Endothelin-1-induced contraction and relaxation of isolated rat basilar artery: effect of the endothelium. J Cardiovasc. Pharmacol 26(Suppl 3): S197-S199, 1995
  62. Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CF. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc Natl Acad Sci USA 88: 7773-7777, 1991 https://doi.org/10.1073/pnas.88.17.7773
  63. Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K, Wada J, Makino H. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 41: 1426-1434, 1998 https://doi.org/10.1007/s001250051088
  64. Takayanagi R, Kitazumi K, Takasaki C, Ohnaka K, Aimoto S, Tasaka K, Ohashi M, Nawata H. Presence of non-selective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett 282: 103-106, 1991 https://doi.org/10.1016/0014-5793(91)80454-B
  65. Tammesild PJ, Hodgson WC, King RG. Increased sensitivity to endothelin-1 in isolated Krebs'-perfused kidneys of streptozotocin- diabetic rats. Clin Exp Pharmacol Physiol 19: 261-265, 1992 https://doi.org/10.1111/j.1440-1681.1992.tb00448.x
  66. Tesfamariam B, Jakubowski J, Cohen RA. Contraction of diabetic rabbit aorta due to endothelium-derived $PGH_{2}/TXA_{2}$. Am J Physiol 257: H1327-H1333, 1989
  67. Tsukahara H, Ende H, Magazine HI, Bahou WF, Goligorsky MS. Molecular and functional characterization of the non-isopeptideselective $ET_{B}$ receptor in endothelial cells. Receptor coupling to nitric oxide synthase. J Biol Chem 269: 21778-21785, 1994
  68. Veelken R, Hilgers KF, Hartner A, Haas A, Bohmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 11: 71- 79, 2000
  69. Wang R, Liu Y, Sauve R, Anand-Srivastava MB. Diabetes-related abnormal calcium mobilization in smooth muscle cells are induced by hyperosmolality. Mol Cell Biochem 183: 79-85, 1998 https://doi.org/10.1023/A:1006813223216
  70. Weksler BB, Marcus AJ, Jaffe EA. Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells. Proc Natl Acad Sci USA 74: 3922-3926, 1977 https://doi.org/10.1073/pnas.74.9.3922
  71. Wheatcroft SB, Williams IL, Shah AM, Kearney MT. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 20: 255-268, 2003 https://doi.org/10.1046/j.1464-5491.2003.00869.x
  72. Wolf PA, Kannel WB, Verter J. Current status of risk factors for stroke. Neurol Clin 1: 317-343, 1983
  73. Wu SQ, Hopfner RL., McNeill JR, Wilson TW, Gopalakrishnan V. Altered paracrine effect of endothelin in blood vessels of the hyperinsulinemic, insulin resistant obese Zucker rat. Cardiovasc Res 45: 994-1000, 2000 https://doi.org/10.1016/S0008-6363(99)00417-4
  74. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki TA. Novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988 https://doi.org/10.1038/332411a0